ART Advanced Research Technologies Inc. (ART), a Canada-based medical device company and provider of optical molecular imaging, saw revenues for Q2 of $829,000 (USD), compared to $752,500 in Q2 2005. However, the company reported a net loss of $3,643,064, compared to $2,701,883 for the same quarter in 2005. For the six-month period ended June 30, 2006, the company’s net loss was $6,785,096, compared to $5,945,577 for the first six months of 2005.